VAERS reports by lot

GSK Varicella/Shingles lot CA374: VAERS reports

28 VAERS reports list lot CA374 as a GSK Varicella/Shingles vaccine, received between 2019-03-15 and 2020-10-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
4%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2926%
Injection-site / Local reaction2623%
Musculoskeletal1312%
Dermatological (non-injection-site)1211%
Neurological109%
Gastrointestinal109%
Psychiatric / Neuropsychiatric44%
Allergic / Anaphylactic33%
Cardiac / Cardiovascular22%
Autoimmune / Immune-mediated11%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
New York4
Michigan2
Montana2
Wisconsin2
Illinois2
Kansas1
Virginia1
Pennsylvania1
Massachusetts1
New Hampshire1
Iowa1

Reports by month received

2019-038
2019-049
2019-053
2019-064
2019-071
2019-081
2019-101
2020-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.